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ABSTRACT
Targeted endonucleases including zinc ﬁnger nu-
cleases (ZFNs) and clustered regularly interspaced
short palindromic repeats (CRISPRs)/Cas9 are in-
creasingly being used for genome editing in higher
species. We therefore devised a broadly applicable
and versatile method for increasing editing efﬁcien-
cies by these tools. Brieﬂy, 2A peptide-coupled co-
expression of ﬂuorescent protein and nuclease was
combined with ﬂuorescence-activated cell sorting
(FACS) to allow for efﬁcient isolation of cell pop-
ulations with increasingly higher nuclease expres-
sion levels, which translated into increasingly higher
genome editing rates. For ZFNs, this approach, com-
bined with delivery of donors as single-stranded
oligodeoxynucleotides and nucleases as messenger
ribonucleic acid, enabled high knockin efﬁciencies
in demanding applications, including biallelic codon
conversion frequencies reaching 30–70% at high
transfection efﬁciencies and ∼2% at low transfection
efﬁciencies, simultaneous homozygous knockin mu-
tation of two genes with ∼1.5% efﬁciency as well as
generation of cell pools with almost complete codon
conversion via three consecutive targeting and FACS
events. Observed off-target effects were minimal,
and when occurring, our data suggest that they
may be counteracted by selecting intermediate nu-
cleaselevelswhereoff-targetmutagenesisislow,but
on-target mutagenesis remains relatively high. The
methodwasalsoapplicabletotheCRISPR/Cas9sys-
tem, including CRISPR/Cas9 mutant nickase pairs,
which exhibit low off-target mutagenesis compared
to wild-type Cas9.
INTRODUCTION
Nuclease-based technologies have opened unprecedented
possibilities for targeted genome editing in numerous
species and cell types previously found challenging for ge-
netic modification. The general principle involves engineer-
ing of endonucleases that can create a double-strand break
at a desired site in genomic deoxyribonucleic acid (DNA)
and vastly stimulate mutagenesis rates at that site. The
technology may exploit natural homing endonucleases with
specificities redirected towards a desired genomic sequence
(1); alternatively, it may exploit non-specific nucleases, such
as FokI, that are targeted to a desired genomic location
via fusion to protein modules engineered to bind a specific
DNA sequence. The latter systems include zinc finger nu-
cleases (ZFNs) (2,3) and transcription activator-like type
II effector nucleases (TALENs) (4). ZFNs and TALENs
functionasheterodimersinwhichtheindividualmonomers
bind offset 9–18-bp target sequences on opposite strands of
DNA and subsequently nick their respective strands to pro-
duce a double-strand break. Recently, clustered regularly
interspacedshortpalindromicrepeat(CRISPR)systemsfor
genome editing have been developed to introduce a double-
strand break by the non-specific nuclease Cas9, which is di-
rected to the desired locus by a 20-nt sequence contained
within a so-called guide ribonucleic acid (gRNA) through
Watson–Crick base pairing with target DNA (5–11). Most
recently, pairs of gRNAs that target offset sequences on op-
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positestrands of thetarget locushavebeenusedinconjunc-
tion with nickase mutants of Cas9. This represents an edit-
ing system that is analogous to that of ZFNs and TALENs
and shows greatly increased specificity as compared to the
single CRISPR/Cas9 approach (12–14).
No matter the type of engineered nuclease used, the
ultimate goal is to produce a site-specific DNA double-
strand break. Such breaks can be resolved via the relatively
error-pronenon-homologousendjoining(NHEJ)pathway,
which often inserts or deletes a number of bases at the
break. If nucleases are targeted to a coding sequence, a
frame shift and functional gene knockout may be the out-
come. Alternatively, the DNA break can be repaired by the
homology-directed repair (HDR) pathway using the sister
chromatidasrepairtemplate.However,ifanexogenous,ho-
mologous DNA template (donor) containing a mutation is
co-delivered into cells along with the nucleases, HDR can
be exploited to precisely modify a genome in a user-defined
manner. Short, homologous single-stranded oligodeoxynu-
cleotides(ssODNs)havealsoprovenhighlyeffectivedonors
(15), exploiting repair mechanisms that are not entirely
clear.
The efficiency of nuclease-based generation of genome-
edited clones from a targeted cell population is affected
by several factors. One critical determinant is nuclease ex-
pression levels. Nucleases are most often delivered to cul-
tured cells by transfection of plasmid- or messenger ribonu-
cleicacid(mRNA)-basedexpressionconstructsandlessfre-
quently via viral or protein delivery (16–19). Regardless
of the method, nuclease delivery efficiencies and the resul-
tant expression levels vary greatly between cell types. Even
withinagivencellpopulation,nucleaseexpressionlevelsof-
ten vary substantially. Consequently, low nuclease expres-
sion levels in individual cells and/or nuclease expression in
only a small fraction of cells often represent a major bar-
rier to the generation of modified clones from a targeted
cell population.
Expression of fluorescent proteins followed by
fluorescence-activated cell sorting (FACS) is a pow-
erful method for tracking cells of interest in a mixed
population and has also been explored for nuclease genome
editing. For instance, a fluorescence-based surrogate target
gene reporter was co-transfected along with the nucleases
and was used to enrich for cells with high nuclease activity
(20). Furthermore, elegantly designed fluorescence-based
reporter systems were used to explore repair mechanisms
underlying nuclease genome editing, showing that elevated
nuclease levels promote NHEJ and HDR and that elevated
donor levels increase HDR whilst suppressing NHEJ (21).
Here, we aimed to devise a FACS-based method for ob-
taining cell populations with desired, high and uniform nu-
clease expression levels from which genome-edited clones
may be derived with increased efficiencies. The method was
basedontightlycoupled(1:1)co-expressionofnucleaseand
fluorescent protein in the same cell. This was achieved via
transfection with constructs in which nuclease and fluores-
cent protein are encoded in the same transcript and linked
by 2A peptide sequence (22), causing expression of nucle-
ase and fluorescent protein as separate entities. Subsequent
FACS allowed for easy isolation of cell populations with
increasingly higher and uniform nuclease expression level
which translated into increasingly higher genome editing
frequencies.
We explored this method in several variations that offer
specific advantages depending on the application: linking
the two nucleases of a pair to distinct fluorescent proteins
for standard genome editing, linking nuclease pairs for dis-
tinctgenestodistinctfluorescentproteinsformultiplexedit-
ing, and consecutive rounds of fluorescent protein/nuclease
delivery and FACS for generation of genome edited cell
pools. In the diverse and often challenging applications
tested, this method was found to greatly increase genome
editing frequencies by ZFNs and CRISPR/Cas9. By com-
bining the method with delivery of ZFNs as mRNA and
donors as ssODNs, generation of biallelic knockin clones
in large numbers was achieved. Observed ZFN off-target
effects associated with the method were minimal. Further-
more, in the event that an off-target effect is encountered,
the method may be exploited to balance ZFNs to levels
where off-target mutagenesis is low, but on-target mutagen-
esisremainssufficientlyhigh.ForCRISPR/Cas9,off-target
effects may be reduced by incorporation of nickase pairs
into the method.
MATERIALS AND METHODS
ZFNs and donors
ZFNs were of the CompoZr ZFN format generated by
Sigma-Aldrich, except for the RSK4 ZFNs that were engi-
neeredbySangamoBiosciences,Inc.TheZFNscontainthe
eHiFi (ELD/KKR) FokI domains and function as obligate
heterodimers with improved catalytic activity (23). The zinc
finger moieties of the dimers were designed to target 30–
33-bp recognition sites in total. The sequences of the major
ZFNs used here (RSK2, RSK4 and PRMT1)a r eg i v e ni n
SupplementaryTableS1.PlasmidandssODNdonors(Sup-
plementary Table S2) were synthesized by Gene Oracle Inc.
and Sigma-Aldrich (Genosys), respectively.
pFluo-2A-ZFN constructs
First,aso-calledpFluo-2A-ZFNconstruct(Figure1A)was
generated to co-express enhanced green-fluorescent pro-
tein (EGFP) (24) and ZFN via the 2A peptide. Briefly, the
EGFP-2A-FLAG-NLS sequence shown in Supplementary
Figure S1 and starting with an EcoRI site and ending with
a KpnI site was synthesized (Gene Oracle, Inc.). This se-
quence was then used to replace the FLAG tag and nuclear
localization signal (NLS) sequences excised from the stan-
dard CompoZr ZFN expression construct, pZFN (which
in this case encoded the left ZFN for a ZFN pair target-
ing human RSK4), using the same restriction endonuclease
sites. The resulting construct was used to generate all other
pFluo-2A-ZFN derivatives reported here for co-expression
of EGFP, the DsRed2 derivative E2 Crimson (25), Venus
(26) or Cerulean (27) together with various ZFNs. First,
fluorescent proteins were swapped by polymerase chain re-
action (PCR) amplification of the fluorescent protein cod-
ing sequence using up- and downstream primers with over-
hangscontainingNsiIandAvrIIsites,respectively,followed
by cloning of the PCR product into the pEGFP-2A-ZFN
construct for RSK4 using these sites. Second, the variousPAGE 3 OF 16 Nucleic Acids Research, 2014, Vol. 42, No. 10 e84
fluorescent protein-2A-FLAG-NLS cassettes were cloned
into pZFNs for various genes using the EcoRI/KpnI sites,
a cloning strategy that works for any CompoZr pZFN con-
struct as long as these sites are absent from the zinc finger
moiety of the construct.
pFP-ZFN and pFP-ZFNL-ZFNR constructs
Alternative versions of pFluo-2A-ZFN, called pFP-ZFN,
werecreated. First, pFP-ZFNL and pFP-ZFNR constructs
weregeneratedthatencodegreen-fluorescentprotein(GFP)
(28,29) and red fluorescent protein (RFP) (30), respectively,
linked to ZFN via a 2A sequence (Supplementary Figure
S7). Fluorescent proteins and ZFNs can be swapped using
the NsiI and KpnI/XhoI restriction sites, respectively. To
combine both ZFNs of a pair into a single, GFP-coupled
construct, the 2A-ZFNR sequence can be excised from a
pFP-ZFNR vector using the restriction enzymes BglII and
XhoI and then inserted into a pGFP-ZFNL construct di-
gested with the same enzymes. The resulting pFP-ZFNL-
ZFNR construct (Figure 3A) contains intervening 2A se-
quencesforco-expressionoffluorescentprotein,ZFNLand
ZFNR as three separate entities.
CRISPR/Cas9 constructs
A single vector construct, pCMV-Cas9-GFP, was gene-
synthesized to co-expresses gRNA targeting the KRAS
or the VEGFA locus under control of the U6 promoter
and Cas9–2A-GFP under control of the cytomegalovirus
(CMV) promoter (Figure 5A). QuikChange mutagenesis
(Stratagene) was used to swap the gRNA in these con-
structs to gRNAs targeting the EMX1 locus as well as to
convert Cas9 into a DNA nickase (Cas9N) by introduction
of the D10A point mutation. Sequences of gRNAs and
mutagenesis primers are provided in Supplementary Tables
S3 and S4, respectively. QuikChange conditions were
standard, except that the extension time was 16 min and
18 cycles were performed to obtain robust amplification.
Furthermore, 5% dimethyl sulfoxide (DMSO) was included
in the reaction mixture. To swap GFP with DsRed2 in
these constructs, a MegaQuikChange strategy was em-
ployed. Briefly, the DsRed2 sequence was PCR amplified
using the following primers: 5 GGAGAATCCTGGCC
CACGATCGATGCATGATAGCACTGAGAACG-3 ;
5 CCTCTAGACTCGAGTCATCAGTTAACCTGGAA
CAGGTGGTGGCGGG-3 . The PCR product was puri-
fied and 200 ng were used as MegaQuikChange primers
using pCMV-Cas9N-GFP as template.
In vitro synthesis of mRNA
mRNA was in vitro synthesized from pZFN or pFluo-2A-
ZFN using the MessageMAX T7 ARCA-Capped Message
Transcription Kit (#EPICMMA60710, Epicentre) and the
Poly A tailing kit (#EPICPAP5104H, Epicentre) and puri-
fied using the MEGAClear kit (Ambion) according to the
manufacturers’ instructions.
Cell culture
K562 and HCT116 cells were cultured in Iscove’s modified
Dulbecco’s medium and McCoy’s 5A medium, respectively,
supplementedwith10%foetalbovineserum.MCF10Acells
weremaintainedinHam’snutrientmixtureF12/Dulbecco’s
modifiedEagle’smedium(1:1)supplementedwith5%horse
serum, 10-g/ml insulin, 20-ng/ml epidermal growth fac-
tor (EGF), 5-g/ml hydrocortisone and 100-ng/ml cholera
toxin. Jurkat cells were cultured in Roswell Park Memorial
Institute-1640mediumsupplementedwith10%fetalbovine
serum.Chinesehamsterovary(CHO)cellsweremaintained
inEX-CELLCHOCDFusionserum-freemedium(Sigma-
Aldrich). All media were supplemented with 1.5-mM L-
glutamine (4 mM for CHO cells), 100-U/ml penicillin and
100-g/ml streptomycin. K562- and Jurkat-conditioned
media were prepared by mixing equal amounts of fresh
medium with medium collected from either cell type cul-
turedat∼0.5×106 cellspermlfor24hthensterilizedusing
a 0.2-m filter (Millipore).
Expression comparison of ZFNs from pFluo-2A-ZFN versus
pZFN
For plasmid transfection, HCT116 cells were plated at 1.2
× 105 cells per 3.8 cm2 well. After 24 h, the cells were trans-
fected with 0.4-g DNA complexed with 2-l TransIT-
LT1 transfection reagent (#MIR2310, Mirus) according
to the manufacturer’s instructions. For mRNA transfec-
tion, HCT116 cells were split and plated at a density lead-
ing to ∼70% confluency at the time of transfection 2 days
later. Cells were then electroporated using a Nucleofec-
tor (Lonza) set to program D-032. 1 × 106 cells were dis-
solved in 100-l Nucleofector Solution V (Lonza) with 2.0-
g and 3.3-g mRNA transcribed from pZFN and pFluo-
2A-ZFN, respectively. The difference in mRNA amounts
used was due to the size difference of the mRNA con-
structs (∼1170 and ∼1950 bps, respectively, plus a poly A
tail of ∼150 bps) and ensured transfection with roughly
equimolar amounts of both mRNA types. Three days post-
transfection, cells were lysed in sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) sample
buffer (2% SDS, 62-mM Tris-HCl pH 6.8, 10% glycerol, 50-
mM dithiothreitol and 0.12% bromophenol blue) and sub-
jected to immunoblotting, as described below.
Functional comparison of ZFNs expressed from pFluo-2A-
ZFN versus pZFN
K562 cells were split 2 days prior to electroporation so that
the concentration of the cells was ∼0.5 × 106 cells per ml
at the time of electroporation. The K562 electroporation
was performed in a Nucleofector (Lonza) using program
T-016 according to the manufacturer’s instructions. Briefly,
1 × 106 cells in 100-l Nucleofector Solution V (Lonza)
were mixed with the following reagents as appropriate for
the experiment: for ssODN donor-based genome editing,
3 l of 100-M RSK4 Cys443Val/BamHI ssODN donor
(equaling ∼6.7 g) in 10-mM Tris (pH 7.6) was used to-
getherwith2-gZFN-expressingplasmid(foreachZFNof
the pair) or with 2-g and 3.3-g ZFN-expressing mRNA
(for each ZFN of the pair), when transcribed from pZFN
and pFluo-2A-ZFN, respectively. For plasmid donor-based
genome editing, 10-g RSK2 Cys436Val/BamHI plasmid
donorwasusedtogetherwith2-gZFN-expressingmRNAe84 Nucleic Acids Research, 2014, Vol. 42, No. 10 PAGE 4 OF 16
when transcribed from pZFN or 3.3-g ZFN-expressing
mRNAwhentranscribedfrompFluo-2A-ZFN.Fourhours
after nucleofection, cells were shifted to 30◦C. Whilst a ben-
eficial effect of this condition termed ‘cold shock’ has so far
only been validated for NHEJ editing, we used it also for
knockin editing, since it was reported to increase cellular
ZFN levels (31). After 3 days, genomic DNA was isolated
as described below.
Genome editing using 2A-coupled co-expression of nuclease
and fluorescent proteins combined with FACS
K562 cells were electroporated with the various constructs
for ZFN or CRISPR/Cas9 2A-linked to fluorescent pro-
tein, as described in the section above and in the main text.
Cells were then cultured for 72 h with a 30◦C cold shock
from 4–68 h (ZFNs only). MCF10A and Jurkat cells were
electroporatedasdescribedforK562exceptthatNucleofec-
torsolutionT/NucleofectorprogramT-020andNucleofec-
tor Solution V/Nucleofector program X-001 were used for
the two cell lines, respectively. In the comparison of the effi-
ciency of ZFN genome editing using non-linked versus 2A-
linked fluorescent protein, the non-linked fluorescent pro-
tein was delivered as 250 ng of pGFP plasmid (contained in
the Nucleofector kit from Lonza).
Three days after transfection, the cells were subjected to
FACS analysis. Briefly, cells (trypsinized if adherent and
thendilutedwithculturemediumtoinactivatetrypsin)were
pelleted by centrifugation at 200 g for 4 min and resus-
pended in normal culture medium to about 0.5–1×106 cells
per ml (NB: optimal cell densities will vary depending on
cell type and whether bulk sorting or single-cell plating is
the goal). Finally, the cells were passed through 50-m fil-
cons (BD Biosciences) to achieve a single-cell suspension.
FACS analysis was performed on an FACS Aria I (BD Bio-
sciences) with excitation and detection of emission as ap-
propriate for the various fluorescent proteins. Fluorescence
levels of mock-transfected cells were determined in parallel
and considered background level, based on which cell pop-
ulations with specific fluorescence signals could be assigned
(see Supplementary Figure S5 for further details). Fluores-
centcellpopulationswerethengatedindefinedfluorescence
intensity intervals (e.g. 50% ± 5% or top 10%) of the total
fluorescent cell population and isolated. To generate stably
modified clones, cells isolated by FACS according to a de-
sired fluorescence level or cells not subjected to FACS were
single-cell sorted into 96-well plates in medium conditioned
as appropriate and expanded to clonal cell lines.
Genomic DNA extraction and PCR amplification
Forsingle-cellclones,DNAwasisolatedwhentheexpanded
cell clones grew dense. Briefly, the cells were washed with a
1X phosphate-buffered saline (PBS) solution, lysed in 70-
l lysis buffer [25-mM NaOH, 0.2-mM ethylenediaminete-
traacetic acid (EDTA), pH 12], then incubated at 95◦C
for 30 min. Thereafter, 70-l neutralization buffer (40-mM
Tris-HCL, pH 5) were added. Of this mixture, 1–3 lw e r e
used as template for PCR for genome editing analysis by re-
striction fragment length polymorphism (RFLP) assay, as
described below.
For bulk-sorted cells, genomic DNA was isolated by in-
cubation of the cells for 3 h at 55◦C in lysis buffer [20-mM
Tris-HCl (pH 8.0), 5-mM EDTA, 400-mM NaCl, 1% SDS,
400-g/ml proteinase K], followed by phenol-chloroform
extraction and isopropanol precipitation of the DNA. Ap-
proximately100ngofgenomicDNAwerethenusedastem-
plate for PCR amplification and genome editing analysis by
CEL-I or RFLP assays, as described below. PCR was car-
ried out in 12.5-l reactions using Taq DNA polymerase
(Ampliqon). The specific annealing temperatures and addi-
tivesforthevariousPCRsarelistedinSupplementaryTable
S5. The following touch-down PCR amplification condi-
tions were used: after an initial 5-min denaturation at 95◦C,
samples were subjected to 15 cycles consisting of denatura-
tion for 30 s at 95◦C, then primer annealing and extension
for 70 s at 70◦C in the first cycle with a 0.5◦C reduction of
annealing/extension temperature in each subsequent cycle.
This was followed by 23–26 cycles of denaturation for 30 s
at 95◦C, primer annealing for 30 s at various temperatures
(provided in Supplementary Table S5) and extension for 70
sa t7 2 ◦C. The reactions were terminated by a final elonga-
tion step of 5 min at 72◦C.
CEL-I assay
CEL-I assays were performed according to the manufac-
turer’s instructions (Transgenomic). Briefly, 10 lo ft h e
PCR products amplified from wild-type and mutant alle-
les were used to generate heteroduplexes using the follow-
ing reaction conditions: an initial 10-min denaturation step
at 95◦C was followed by 1 s at 95◦C and a step-wise 2◦Cr e -
duction in temperature with 1-s incubations down to 85◦C,
then 1 s at 85◦C and a step-wise 0.1◦C reduction in tem-
perature with 2-s incubations down to 4◦C. Next, the reac-
tionswereincubatedat42◦Cfor30minwith0.4lofSUR-
VEYOR Nuclease S (CEL-I) and SURVEYOR Enhancer S
(#706025,Transgenomic).One-tenthofthePCRvolumeof
StopSolutionwasaddedtoterminatethereactions.Finally,
the digests were resolved on 6% or 8% Tris-borate-EDTA
(TBE) acrylamide gels, depending on the anticipated band
sizes.SupplementaryTableS5provides thesequencesofthe
primers used, as well as the sizes of diagnostic fragments
and PCR products amplified from the targeted alleles.
RFLP assay
PCR reactions were digested by addition of 10 U of
the appropriate restriction endonuclease and incubation
overnight at 37◦C. Digests were resolved on either 6% or
8% TBE acrylamide gels, or on 1–2% 0.5 x Tris-acetate-
EDTA (TAE) agarose gels, depending on the anticipated
band sizes. When analysing clonal cell lines, mono- and
biallelic knockin of diagnostic restriction sites in diploid
loci were evidenced by ∼50% and complete digestion of
the PCR products, respectively (see Supplementary Figure
S4 as an example). For triploid loci, triallelic knockin was
evidenced as complete digestion, whereas partial digestion
(∼30–60%) was taken as mono- or biallelic knockin. Sup-
plementary Table S5 provides the diagnostic restriction en-
donucleases, sequences of the primers used, as well as the
sizes of diagnostic fragments and PCR products amplified
from the targeted alleles.PAGE 5 OF 16 Nucleic Acids Research, 2014, Vol. 42, No. 10 e84
Densitometric quantization of CEL-I and RFLP assays
Gels with digested PCR products were stained for 10 min
with ethidium bromide and imaged with a Quantity One
GelDocXRimagingsystem(Bio-Rad).Quantificationwas
performed using ImageJ software (Rasband, W.S., ImageJ,
U.S. National Institutes of Health, Bethesda, Maryland,
USA, http://imagej.nih.gov/ij/, 1997–2012) and based on
relative intensities of uncleaved versus cleaved PCR prod-
ucts, and percentage cleavage was determined using the for-
mula: % cleavage = 100 x (1-(1-fraction cleaved) 1/2).
Off-target analysis
To predict candidate off-target sites for the human RSK4
and RSK2 ZFNs, the Homo sapiens genome (GRCh37,
hg19) was scanned for sequences highly homologous to
their on-target sites. To predict candidate off-target sites for
the various CHO ZFNs, the Cricetulus griseus genome ver-
sion1.0wasdownloadedfromNCBI(ID:AFTD01000000)
and indexed for use with Bowtie (32) for alignment with
the relevant ZFN on-target sites. The Phred score thresh-
old was set to 160, which in our case thus searched for sites
with up to five mismatches per monomer binding site. Fi-
nally, 100-bps up- and downstream of the candidate sites
were extracted for primer design for genomic PCR. For
both human and hamster, a 5- or a 6-bp spacer sequence
between the ZFN monomer binding sites was allowed. Fur-
thermore, searches were restricted to heterodimeric loca-
tions since the ZFNs used contain obligate heterodimeric
FokI (ELD/KKR) domains, which have previously been
shown to eliminate off-target activity at homodimeric tar-
get locations (33).
To perform Sanger sequencing of candidate off-target
sites, the appropriate genomic loci were PCR amplified us-
ing primers listed in Supplementary Table S5. The result-
ing PCR products were then purified using carboxyl-coated
magnetic beads. Briefly, an equal volume of PCR product
and hybridization buffer (2.5-M NaCl, 20% polyethylene
glycol (PEG) 8000) supplemented with 10 lo f1 0m g /ml
beads pre-washed three times with 0.5-M EDTA (#21353,
Pierce) were mixed and incubated for 10 min at room tem-
perature. Then, magnetic beads with bound PCR products
were captured using a magnetic stand for 5 min and washed
three times with 70% ethanol. The beads were air-dried and
re-suspended in 20 l 10-mM Tris-HCl pH 8.0 buffer. For
sequencing (GATC Biotech), 20–80 ng/l of the purified
PCR products were pre-mixed with 25 pmol (in 5 l) of the
appropriate sequencing primers (Supplementary Table S5).
Gene copy number analysis
Genomic DNA was extracted from K562 and Jurkat cells
using the FlexiGene DNA kit (Qiagen) and subjected to
genecopynumberanalysis(performedattheCenterforGe-
nomic Medicine, Rigshospitalet) using CytoScan HD ar-
rays (Affymetrix). Briefly, 250 ng of genomic DNA were
digested and ligated to adapters. Adapter-ligated DNA
was amplified, purified, fragmented, labelled with biotin
and hybridized to the arrays for 18 h. The Fluidics Sta-
tion 450 (Affymetrix) and the GeneChip Scanner 3000 7G
(Affymetrix) were used to wash, stain and scan the arrays.
The generated .CEL files were then analysed in Partek Ge-
nomics Suite 6.6. Briefly, data were imported using the rec-
ommended default Partek settings: probes were adjusted
for probe sequence, settings for no background and quan-
tile normalization were applied and probes were allele-
specifically summarized. Gene copy number and single nu-
cleotide polymorphism (SNP) allele ratio were calculated
using an unpaired analysis with the baseline distributed by
Partek, which is based on 380 CytoScan HD array from the
International HapMap project. Copy number status of in-
dividual genes was established by examining copy number
calls combined with the SNP allele ratios, whilst also taking
polyploidy into account.
Stimulation and isolation of RSK2 for functional codon con-
version assay
To assay RSK2 activity, wild-type or RSK2-Cys436Val
K562cellsplatedat2×106 cellsperwellwereserum-starved
for 4 h and then incubated for 1 h with 10-M fmk.Afi -
nal 20-min incubation with 100-nM phorbol 12-myristate
13-acetate (PMA) was included, when indicated. The cells
were solubilized for 15 min in 1-ml lysis buffer [300-mM
NaCl, 50-mM Tris-HCl (pH 7.4), 0.5% Igepal CA-630, 1-
mM Na3VO4, 5-mM EDTA, 50-mM NaF, 10-nM calyculin
A, 10-M leupeptin, 5-M pepstatin and 1-g/ml apro-
tinin] on ice and manipulated at <4◦C thereafter. Cell ex-
tracts were clarified by centrifugation for 5 min at 18 000 g
andthesupernatantswereincubatedfor90minwith2gof
anti-RSK2 antibody (MCA3429Z, ABC Serotec), with the
addition of 20-l protein G agarose beads (#16–266, Up-
state) during the final 30 min. The beads were then precipi-
tated by centrifugation, washed five times with lysis buffer,
drained and dissolved in SDS-PAGE sample buffer.
Immunoblot analysis
Immunoprecipitated RSK2 and extracts of cells transfected
with ZFN and fluorescent protein expression constructs
were subjected to SDS-PAGE and the proteins were then
transferredtoHybond-ECLnitrocellulosemembranes(GE
Healthcare). Membranes were blocked with 2% (w/v) ECL
Advance Blocking Agent (GE Healthcare), followed by in-
cubation with primary antibodies against active (Ser386-
phosphorylated) RSK2 (#AF1094, R&D Systems), total
RSK2 (MCA3429Z, ABC Serotec), FLAG epitope tag
(horse radish peroxidase-coupled, #F3165, Sigma), EGFP
(#8334, Santa Cruz Biotechnology; this antibody was also
used to detect Venus and Cerulean) or DsRed2 antibody
(#632496, Clontech), as appropriate. Thereafter, relevant
horseradish peroxidase-coupled secondary antibodies and
ECL Advance (GE Healthcare) were used for visualization
of the primary antibodies.
RESULTS
Generation of a plasmid construct (pFluo-2A-ZFN) for
tightly coupled co-expression of fluorescent protein and ZFN
as separate entities
We first created the construct pFluo-2A-ZFN that encodes
a fluorescent protein linked to a ZFN via a 2A peptide se-e84 Nucleic Acids Research, 2014, Vol. 42, No. 10 PAGE 6 OF 16
Figure 1. High-efficiency genome editing via 2A-coupled co-expression of ZFNs and fluorescent proteins combined with FACS. (A) Schematic of the
pFluo-2A-ZFN construct for 2A-coupled, 1:1 co-expression of ZFN and fluorescent protein. Functional parts indicated are CMV promotor, fluorescent
protein (Venus, Cerulean, DsRed2, EGFP), 2A peptide, triple FLAG epitope tag, nuclear localization signal (NLS), zinc finger (ZF) moiety and FokI
nuclease moiety. The restriction endonuclease sites NsiI/AvrII and EcoRI/KpnI can be used to swap fluorescent protein and ZFN, respectively. (B) Fluo-
rescent protein and ZFN expressed from Fluo-2A-ZFN transcripts are co-expressed as separate entities due to translational skipping at the 2A sequence.
(C) Overview of strategy for high-efficiency genome editing via FACS isolation of cells that co-express fluorescent protein and ZFNs. In this example, left
and right ZFNs of a pair (ZFNL and ZFNR) have been coupled to distinct fluorescent proteins. (D) FACS profile of K562 cells 3 days after transfection
with mRNA for EGFP-2A-ZFNL and DsRed2–2A-ZFNR targeting the RSK4 locus along with an ssODN knockin donor (RSK4 Cys443Val/BamHI).
Cells from populations displaying low to high EGFP/DsRed2 double-fluorescence intensities (a)–(e) were FACS isolated and single-cell seeded for clonal
expansion. Cells in the gate Q3 have fluorescence intensities similar to mock-transfected cells. (E) Frequency of monoallelic and biallelic knockin modifi-
cation at (i) the diploid RSK4 locus in clonal cell lines derived from populations (a)–(e)o ra t( ii) the diploid RSK2 locus in a similar knockin experiment
using reagents for RSK2 and analysing populations (a)a n d( c) only. Except for population (e) that was isolated only once, the data are means + SD of
three independent experiments. (F) Functional codon conversion at the RSK2 locus. Wild-type or clonal K562 cells with biallelic Cys436Val knockin
modification of RSK2 derived from (c) in panel (E) were analysed for sensitivity of RSK2 to fmk by immunoblot analysis after exposure of cells to the
stimulus PMA in the absence or presence of fmk. The data are representative of those obtained with five clones analysed. (G) Genomic sequence of an
RSK2 Cys436Val clone, indicating the ZFN-binding sites (black bars), the Val436 codon (red bar) and the diagnostic SfcI site (green bar). The mutations
introduced are boxed. Those occurring in the ZFN target site aimed to prevent re-cutting of the locus once the donor had been knocked in.PAGE 7 OF 16 Nucleic Acids Research, 2014, Vol. 42, No. 10 e84
quence in one single reading frame (Figure 1A and Supple-
mentary Figure S1). The 2A peptide undergoes a transla-
tional ribosomal skip of the glycyl-prolyl peptide bond at
its C-terminus, which results in the expression of fluores-
cent protein and ZFN as two separate entities (Figure 1B).
Of note, 2A-based approaches are superior with respect to
producing 1:1 co-expression levels of proteins of interest,
as compared to other co-expression methods (22). We de-
signed pFluo-2A-ZFN such that a single cloning step can
swap fluorescent protein (including EGFP, Venus, DsRed2
and Cerulean) by using the sites NsiI/AvrII and ZFN by
using the sites EcoRI/KpnI.
pFluo-2A-ZFN can co-express diverse fluorescent proteins
and ZFNs at normal expression and activity levels
Next, we determined whether pFluo-2A-ZFN expresses the
fluorescent protein and ZFN coding sequences as sepa-
rate entities and whether ZFN expression and activity lev-
els were comparable to those obtained with the CompoZr
pZFN construct from which we derived pFluo-2A-ZFN.
HCT116 cells were transfected with pZFN or pFluo-2A-
ZFN encoding a variety of fluorescent proteins linked to ei-
thermonomerofvariousZFNpairs,denominatedZFNleft
(ZFNL) and ZFN right (ZFNR). Two days after transfec-
tion,thecellsweresubjectedtoimmunoblotanalysisforthe
fluorescent protein or the FLAG epitope tag present in the
ZFNs. In all instances, pFluo-2A-ZFN expressed the ZFN
moieties cleaved from fluorescent protein at levels similar to
those expressed from pZFN (Supplementary Figure S2A).
Whereastheaboveexperimentsusedplasmid-basedZFN
delivery, ZFN coding sequences can also be delivered into
cells as mRNA synthesized in vitro from vectors that con-
tain the appropriate elements. When delivered as mRNA,
Fluo-2A-ZFN constructs also expressed cleaved ZFNs at
levels identical to those derived from pZFN (Supplemen-
tary Figure S2B). Furthermore, pFluo-2A-ZFN was of
comparable efficiency to pZFN in serving as a template for
in vitro synthesis of mRNA (Supplementary Figure S2C).
TotestwhetherFluo-2A-ZFNexpressesZFNsthatfunc-
tioneffectively,humanleukemicK562cellsweretransfected
with various derivatives of this construct, either as plas-
mid or mRNA. Along with the ZFN constructs, we co-
transfected plasmid or ssODN donor aiming to introduce
a specific codon-swap mutation as well as a silent diagnos-
tic restriction endonuclease site in the targeted genes (the
sequences of donors are provided in Supplementary Table
S2). Three days post-transfection, the cells were lysed and
the cell lysates were used as template to PCR amplify ge-
nomic sequence spanning the mutation sites. The resulting
PCR products were subjected to two different assays that
both detect mutagenesis at the target site: either CEL-I as-
say that detects any alterations at the target site or RFLP
assay that specifically detects knockin of the diagnostic re-
striction site. Both assays revealed that ZFNs derived from
either pZFN or pFluo-2A-ZFN produced similar levels of
genome editing. This was observed regardless of whether
the ZFNs were delivered as plasmid or mRNA or whether
the donor was plasmid or ssODN (Supplementary Figure
S3). Note that these knockin experiments with plasmid and
mRNA ZFN constructs were performed on different oc-
casions and cannot be compared. In side-by-side compar-
isons, we find that mRNA constructs are often the more ef-
ficient for knockin, as we reported previously (15).
Controlled low to high knockin editing frequencies by com-
bining 2A-coupled co-expression of fluorescent proteins and
ZFNs with FACS
We next tested whether transfection with Fluo-2A-ZFN
constructs followed by FACS for isolation of ZFN trans-
fectants can be used to increase the efficiency of genome
editing, as assessed in clonal cell lines. We first focused on
knockin editing, which is relatively demanding, and chose
to deliver donors as ssODNs and nuclease constructs as
mRNA, since these delivery forms offer various advantages
over double-strand DNA construct delivery, as detailed in
the Discussion section.
First, we transfected K562 cells with mRNA constructs
in which each ZFN of a pair was 2A-coupled to a dis-
tinct fluorescent protein: EGFP for ZFNL and DsRed2
for ZFNR. The ZFNs targeted the RSK4 locus which was
found to be diploid in these cells by CytoScan HD array-
based gene copy number analysis (Supplementary Table
S6). Along with the ZFNs, we co-transfected an ssODN
donor (RSK4 Cys443Val/BamHI) designed to knockin a
specific codon-swap mutation and a silent diagnostic re-
striction site in RSK4. FACS analysis 3 days after transfec-
tion revealed that the expression levels of both EGFP and
DsRed2varied∼100-foldinthecellpopulation(Figure1D,
Q2),illustratingthegreatlackofuniformexpressionincells
of a transfected cell pool. Also, a fraction of the fluores-
centcellswereDsRed2positiveonly(Figure1D,Q4:∼1.7%
of the cells), thus apparently expressing only one ZFN of
the pair, which is incompatible with respect to genome edit-
ing. Using FACS, we next isolated cell populations that
displayed uniform EGFP and DsRed2 double-fluorescence
levels ranging from low to high (Figure 1D, a–e), aiming to
recapitulate the finding in the model system by Certo et al.
that increased nuclease levels result in increased editing fre-
quencies (21). Thereafter, cells from each population were
single-cell sorted into 96-well plates and expanded to clonal
cell lines. The expanded clones were analysed using RFLP
assay to detect knockin of the diagnostic restriction site in a
monoallelicorbiallelicstateattheRSK4locus(Supplemen-
tary Figure S4). Three striking results were obtained [Fig-
ure 1E, (i)]. First, the knockin frequencies in the clones in-
creased with the fluorescence level observed in the cells at
the time of FACS and single-cell plating. Second, ∼95% of
the 264 clones derived from the most highly fluorescent cell
population ‘e’ had the diagnostic knockin mutation and, of
these, ∼70% had biallelic modification of the targeted lo-
cus. Finally, a total of 520 biallelic knockin clonal cell lines
were rapidly generated using this high-throughput genome
editing method that was streamlined for 96-well plate for-
mat and multi-channel pipette handling from FACS to the
final step of genotyping of clones by RFLP assay.
In a similar experiment, we targeted the RSK2 locus
in K562 cells using mRNA for ZFNL coupled to EGFP
and ZFNR coupled to DsRed2. Along with ZFNs, we co-
transfected an ssODN donor (RSK2 Cys436Val/SfcI) de-
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agnostic restriction site in the RSK2 locus, which was found
to be diploid in K562 cells by gene copy number analysis
(Supplementary Table S6). Three days after transfection,
EGFPandDsRed2double-fluorescentcellswereFACSiso-
lated from populations with fluorescence levels similar to
‘a’ and ‘c’ in Figure 1D, single-cell plated and expanded to
clonal cell lines. The resulting cell lines were shown to har-
bour low (∼0.6%) and high (∼64%) stable knockin mod-
ification, respectively, of the RSK2 locus [Figure 1E, (ii)].
Of note, biallelic knockin clones constituted ∼29% of those
derived from population ‘c’.B yc o n t r a s t ,i na ne a r l i e rs t u d y
using the same reagents (except for minor differences in the
donor), but where we did not implement FACS enrichment,
only 2.7% biallelic knockin modification of the RSK2 locus
was obtained (15). According to RNA-seq analysis, RSK4
is expressed at >1000 times lower levels compared to RSK2
inK562cells(ourunpublisheddata),yetthetwogeneswere
knockin modified with rather similar efficiencies.
We developed the present high-throughput knockin
method with the aim of genetically manipulating the phar-
macological sensitivity of many different protein kinases in
diverse cell lines. For instance, the Cys436Val codon-swap
knockin mutation introduced in RSK2 in Figure 1E aimed
at rendering thiskinase insensitivetothesmall-moleculein-
hibitor fmk. We tested whether such functional codon con-
version had occurred in our clones by immunoblot analy-
sis for active RSK2 in cells exposed to the stimulus PMA
in the absence or presence of fmk. As shown in Figure
1F, the targeting event generated RSK2-Cys436Val mutant
kinase that was expressed and activated similar to wild-
type RSK2, but was rendered insensitive to fmk,a sp r e -
dicted. Genomic sequencing of the RSK2-Cys436Val clone
revealed homozygous knockin of the desired alterations at
the RSK2 locus (Figure 1G).
Challenging knockin applications are facilitated by the use of
2A-coupled co-expression of fluorescent proteins and ZFNs
We next tested the ability of our method to enrich for rare
targeting events. First, we knockin-targeted the RSK4 lo-
cus by transfecting K562 cells with the same reagents as
in Figure 1D. We thereafter diluted the transfected cells
with mock-treated cells to obtain a cell pool in which the
transfected cells constituted only ∼0.5% of the total cell
population. Unsorted cells from this pool were single-cell
cloned,whilstanotherportionofthecellpoolwassubjected
to FACS enrichment for cells displaying EGFP/DsRed2
double-fluorescence followed by single-cell cloning. The
non-sorted cell pool yielded no modified clones out of 810
clones analysed (Figure 2A, upper panel). In contrast, the
FACS-enriched pool yielded 10 monoallelic (6%) and five
biallelic(3%)knockinclonesoutofthe171clonesanalysed,
demonstrating that our method can enrich for rare target-
ing events in this partial model of an inefficient transfection
scenario.
We next tested our method for knockin editing of ac-
tual difficult-to-transfect cells such as human leukemic Ju-
rkat T cells. Again, we used the reagents described above
to edit the RSK4 locus, which was found to be triploid
in Jurkat cells by gene copy number analysis (Supplemen-
tary Table S6). In parallel, we transfected K562 cells with
the same reagents and also mock-transfected both Jurkat
and K562 cells with irrelevant mRNA not encoding fluo-
rescentprotein.Threedayspost-transfection,FACSprofiles
were established (Supplementary Figure S5). The profiling
in mock-transfected cells in Supplementary Figure S5B de-
fined the cell populations (Q3) devoid of detectable spe-
cificfluorescencesignalfromtransfectedEGFPorDsRed2.
Based on these data, cell populations with specific EGFP
signal (Q1), specific DsRed2 signal (Q4) or specific sig-
nals for both EGFP and DsRed2 could be assigned in the
FACS profiles in Supplementary Figure S5A. Comparing
the various FACS profiles demonstrated a lower transfec-
tion efficiency of Jurkat cells, as compared to K562 cells:
thus, a much larger fraction of the Jurkat cell population
was present in Q3. Furthermore, the expression levels were
also lower in the Jurkat cell population, as evidenced by
many fewer medium and highly fluorescent cells, in partic-
ular EGFP/DsRed2-double fluorescent cells, as compared
to the K562 cell population. Importantly, however, when
sorting for the 15% most highly EGFP/DsRed2 double-
fluorescent Jurkat cells prior to single-cell plating, we ob-
served an ∼8-fold increase in the isolation of clones with
targeted knockin at the RSK4 locus, as compared to non-
sorted cells (Figure 2A, lower panel). Moreover, sorting
even produced one triallelic knockin clone amongst the 14
clones analysed.
In the challenging Jurkat cells, we also tested the ad-
vantage of 2A-coupled co-expression of ZFN and fluores-
cent protein as compared to non-coupled co-expression, in
which ZFN and fluorescent protein are expressed from sep-
arate constructs. Thus, Jurkat cells were either transfected
withmRNAforEGFP-2A-ZFNLandDsRed2–2A-ZFNR
or with mRNA for ZFNL and ZFNR along with a sepa-
rate plasmid expressing EGFP. Again, the ZFNs targeted
the RSK4 locus and the aforementioned ssODN donor
Cys443Val/BamHI were co-transfected for knockin in this
gene. Prior to sorting, the level of modification in the two
cell pools was found to be similar by CEL-I assay and thus
the separate EGFP construct did not negatively affect the
non-coupled ZFNs (data not shown). Furthermore, FACS
analysis showed that the fraction of EGFP fluorescent
and EGFP/DsRed2 double-fluorescent cells were similar
(∼35%) in the two cell pools (Supplementary Figure S6A).
The two cell pools were then sorted for EGFP fluorescence
and EGFP/DsRed2 double-fluorescence, respectively, and
single cells were plated out for clonal expansion. As shown
inSupplementaryFigureS6B,2A-coupledco-expressionof
ZFN and fluorescent protein increased the knockin edit-
ing frequency ∼6-fold as compared to non-coupled co-
expression. Thus, 2A-coupled co-expression produced five
mono/biallelic and one triallelic knockin clone out of 174
clones, whereas non-coupled co-expression produced only
one mono/biallelic knockin clone out of 171 clones. The
lowerknockinfrequenciesobtainedinthisexperimentcom-
pared to that in Figure 2A are due to the fact that we sorted
for cells showing any fluorescence level, as compared to
sorting for the top-15% expressers in Figure 2A.
We extended our approach to investigate whether it
could enable simultaneous knockin modification of two
genes at all alleles in the same cell. K562 cells were co-
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Figure 2. Fluorescent protein-2A-ZFN constructs enable efficient knockin genome editing in demanding applications. (A) K562 or Jurkat cells were
transfectedwithmRNAexpressingEGFP-2A-ZFNLandDsRed2–2A-ZFNRforRSK4alongwithanssODNknockindonor(RSK4Cys443Val/BamHI).
For K562, the cells were diluted 3 days post-transfection with mock-transfected cells to produce a pool of ∼0.5% ZFN-expressing cells. Cells of this
pool were seeded singly or subjected to FACS isolation of EGFP/DsRed2 double-fluorescent cells (any level) that were thereafter also seeded singly. For
Jurkat, non-sorted cells or cells FACS isolated from the 15% most highly EGFP/DsRed2 double-fluorescent cell population were seeded singly 3 days
post-transfection. In both experiments, the singly seeded cells were expanded to clonal cell lines and analysed for knockin mutation by RFLP analysis. For
K562, data are means + range of two independent experiments. (B) K562 cells were co-transfectedwith mRNA expressing EGFP-2A-ZFNs(left and right)
for RSK4 and DsRed2–2A-ZFNs (left and right) for PRMT1 along with ssODN donors for knockin modification of these loci (RSK4 Cys443Val/BamHI
and PRMT1 ScaI). Three days after transfection, non-sorted cells or cells FACS isolated from the 15% most highly EGFP/DsRed2 double-fluorescent
cell population were seeded singly, expanded to clonal cell lines and analysed for complete knockin modification of the RSK4 and PRMT1 loci. Data are
summed of three independent experiments. (C) Overview of strategy for generation of cell pools with high levels of stable knockin modification. In this
case, left and right ZFNs of a ZFN pair (ZFNL and ZFNR) have been coupled to distinct fluorescent proteins. (D) Example of close to 100% knockin in
an MCF10A cell pool. Specifically, MCF10A cells were transfected for codon-conversion knockin at the RSK2 locus as described in Figure 1E, (ii). Three
days after transfection, the 40% most highly fluorescent cells were FACS isolated and cultured as a pool for 2 weeks. Thereafter, this cell pool was subjected
to the same treatment for two more rounds. After the third round, the cell pool was analysed for stable knockin at the RSK2 locus by RFLP analysis with
untreatedMCF10Acellsservingasacontrol.PCRproductsderivedfromwild-typeandmutantallelesareindicatedbyanasteriskandarrows,respectively.e84 Nucleic Acids Research, 2014, Vol. 42, No. 10 PAGE 10 OF 16
Figure 3. pFP-ZFNL-ZFNRsingle vector genomeediting. (A) Schematic
ofapFP-ZFNL-ZFNRvectorthatco-expressesbothZFNsofapairalong
with a fluorescent protein (FP) from the same transcript and as three sepa-
rateentities.FunctionalpartsindicatedareasinFigure1A.(B)Jurkatcells
were transfected with mRNA for a GFP-ZFNL-ZFNR construct target-
ing the RSK2 locus. Three days after transfection, genomic DNA was iso-
lated from non-sorted cells or from cells FACS isolated for low, medium
or high GFP fluorescence intensities and analysed by CEL-I assay. PCR
products containing amplicons derived from mutant RSK2 alleles or from
wild-type alleles only are indicated by arrows and an asterisk, respectively.
The experiment was repeated three times with similar results. N.D.: none
detected.
(L and R) for RSK4 as well as DsRed2-linked ZFNs (L
and R) for PRMT1 (triploid in these cells––Supplementary
Table S6), along with ssODN donors for knockin mod-
ification of each locus (RSK4 Cys443Val/BamHI and
PRMT1 ScaI). Three days after transfection, cells were
subjected to FACS and cells from the 15% most highly
EGFP/DsRed2 double-fluorescent population were single-
cell cloned. Strikingly, FACS enrichment enabled simulta-
neous homozygous knockin mutation of the two genes at
all five alleles in two clones out of 132, whereas no homozy-
gously modified clones were present amongst 185 clones
from unsorted cells (Figure 2B).
Some cell lines and primary cells are inherently recalci-
trant to single-cell cloning and so it may be necessary to
create pools of cells that are highly enriched for the de-
sired mutation. To this end, we evaluated the utility of sev-
eral rounds of ZFN transfection and FACS on a cell pop-
ulation to generate pools of cells with high knockin mu-
tation levels (Figure 2C). Human immortalized, but non-
transformed, mammary MCF10A cells that are difficult
to expand from single cells after FACS were transfected
with EGFP-2A-ZFNL and DsRed2–2A-ZFNR mRNA
for RSK2 and the aforementioned ssODN donor RSK2
Cys436Val/SfcI. Three days after transfection, the 40%
most highly EGFP/DsRed2 double-fluorescent cells were
isolated by FACS, followed by 2 weeks in culture. There-
after, this cell population was subjected to the same treat-
ment two more times. Strikingly, after three rounds of treat-
ment, a pool of MCF10A cells had been obtained with
nearly complete targeted codon conversion at the RSK2 lo-
cus [diploid in these cells, (34)], as evidenced by the nearly
completedigestionintheRFLPassayperformedonthecell
pool (Figure 2D).
Single vector fluorescent protein-ZFNL-ZFNR methods
To further expand the utility of our approach, we generated
variants of the Fluo-2A-ZFN construct, specifically pFP-
ZFN constructs that can rapidly be converted into pFP-
ZFNL-ZFNRconstructsthatencodebothZFNmonomers
ofapaircoupledtoasinglefluorescentprotein(Figure3A).
First,pFP-ZFNvectorsweregeneratedtoencodeGFPand
RFP 2A-coupled to ZFNL and ZFNR, respectively (Sup-
plementary Figure S7). To combine both ZFNs into a sin-
gle, GFP-coupled construct, the 2A-ZFNR sequence can
be excised from a pRFP-ZFNR vector using the restriction
enzymes BglII and XhoI and inserted into a pGFP-ZFNL
construct digested with the same enzymes. Intervening 2A
sequences ensure that each of the three functional compo-
nents is expressed as a separate entity. We tested a pGFP-
ZFNL-ZFNR construct for NHEJ-based modification in
the Jurkat cell line. To this end, Jurkat cells were trans-
fectedwithmRNAencodingGFP-ZFNL-ZFNRforRSK2
(triploid in these cells––Supplementary Table S6). Three
dayslater,thecellswereleftunsortedorwereFACSisolated
for low, medium or high fluorescence intensities roughly
corresponding to populations ‘a’, ‘b’ and ‘d’ in Figure 1D).
SubsequentCEL-IassayshowednodetectableNHEJmod-
ification in the unsorted, low or medium fluorescent cell
pools. By contrast, in the highly GFP positive cell pool,
∼18% of the alleles were modified (Figure 3B), demonstrat-
ing that FP-ZFNL-ZFNR constructs work effectively.
Off-target effects associated with FACS enrichment for cells
with high ZFN levels
We assessed whether enrichment for cells with high ZFN
levels was associated with high off-target cutting. First, we
analysedalargenumberofK562knockinclonesestablished
from cell populations with high levels of ZFNs, specifically,
the populations ‘d’/‘e’f o rRSK4 and ‘c’f o rRSK2,a sd e -
picted in Figure 1E. We only analysed clones with bial-
lelic (complete) knockin, since these may generally repre-
sent clones derived from cells with particularly high levels
of ZFN activity and may therefore also be most suscepti-
ble to off-target cutting. We queried the human genome for
sequences with the highest similarity to the target sites of
theRSK4andRSK2ZFNs,thenanalysedtop-rankingcan-
didate off-target sites for mutations by Sanger sequencing.
Strikingly, no mutations were detected when analysing four
top-ranking off-target sites in ∼300 clones, probing a total
of2372alleles(Figure4A).Theseoff-targetsiteshadfourto
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Figure 4. Off-target cutting associated with FACS for high ZFN levels in K562 cells. (A) K562 clones with biallelic knockin at the RSK4 and RSK2
loci established from the populations ‘d’/‘e’a n d‘ c’ in Figure 1E, respectively, were analysed for mutations in four top-ranking candidate off-target sites
(off-targets 1–4) by Sanger sequencing. The ZFN on-target site is indicated in red and mismatches in off-target sites relative to the target site are boldface.
The spacer sequence between the ZFN monomer binding sites is in italics. (B) K562 cells were transfected with EGFP-2A-ZFNL and DsRed2–2A-ZFNR
for RSK4 or RSK2 along with ssODN donors for either gene. Three days later, genomic DNA was isolated from the 20% most highly fluorescent cell
population and analysed by CEL-1 assay for modification at the target site as well as the four off-target sites shown in panel (A). PCR products containing
amplicons derived from mutant alleles or PCR products derived from wild-type alleles only are indicated by the arrows and asterisks, respectively. The
experiment was repeated three times with similar results. N.D.: none detected.
The absence of off-target mutagenesis in clones derived
from cells with high levels of above ZFNs was confirmed by
complementary analyses. Thus, CEL-I assays failed to de-
tect mutations in any of the above sites in pooled genomic
DNA isolated from highly double-fluorescent cell popula-
tions 3 days after transfection with EGFP-2A-ZFNL and
DsRed2–2A-ZFNR for RSK4 or RSK2 along with the
aforementioned ssODN donor for either gene (Figure 4B).
Neither did CEL-I assays detect any mutations in an addi-
tionalsixtop-rankingcandidateoff-targetsiteswithsixand
seven mismatches relative to the on-target site of the RSK4
and RSK2 ZFNs, respectively (Supplementary Figure S8).
We further assessed the issue of off-target cutting by
analysing a number of CHO cell lines with knockout of
enzymes in the protein glycosylation pathway that we gen-
erated using our method. The clones had biallelic, NHEJ-
derived knockout of either of four genes and were estab-
lished from the top 2–18% most highly double-fluorescent
cell populations after transfection with the relevant EGFP-
2A-ZFNL and DsRed2–2A-ZFNR constructs (data not
shown).Onlyonemonoallelicoff-targetmutationwasiden-
tified by Sanger sequencing of various top-ranking off-
target sites for the four ZFNs in a number of clones, with a
total of 94 alleles probed (off-target 1 for B4GALT4 ZFNs;
Supplementary Figure S9A and C).
CEL-I assay on cell pools 3 days after transfection with
B4GALT4 ZFNs confirmed that these ZFNs had a propen-
sity to cut off-target site 1 upon sorting for high expres-
sion levels, but with a lower efficiency than the on-target
site (Supplementary Figure S9B). We therefore also anal-
ysed modification of both these sites in cells FACS en-
riched for medium ZFN levels to test if it was possible to
generate a cell population with an even more favourable
on/off-target mutagenesis ratio. Interestingly, in the popu-
lation with medium ZFN levels, detectable off-target cut-
ting was eliminated, whilst the on-target modification re-
mained high.
CRISPR/Cas9-based genome editing is facilitated using the
2A-coupled fluorescent protein/FACS enrichment strategy
To explore our method in relation to other nucleases used
for genome editing, we generated a construct expressing
Cas9–2A-GFP under control of the CMV promoter as well
as the gRNA sequence for the target gene driven by the
U6promoter(pCMV-Cas9-FP;Figure5A).K562cellswere
transfected with this construct encoding gRNA targetinge84 Nucleic Acids Research, 2014, Vol. 42, No. 10 PAGE 12 OF 16
Figure 5. CRISPR/Cas9 genome editing is enhanced using the 2A-coupled fluorescent protein/FACS strategy. (A) Schematic of a construct, pCMV-
Cas9-FP, that co-expresses gRNA and Cas6–2A-fluorescent protein. Functional parts indicated are U6 promoter, guide (g)RNA, CMV promoter, Cas9
nuclease, 2A peptide and fluorescent protein (GFP). (B)–(D) K562 cells were transfected (B) with a Cas9-GFP construct targeting the KRAS locus, (C)
with a Cas9-GFP construct targeting the VEGFA locus or the same construct containing a nickase version of Cas9 (Cas9N) or (D) with such constructs
targeting the EMX1 locus as a nickase pair or as individual nickases coupled to GFP or dsRed2. An ssODN donor (EMX1 gRNA 1/2 EcoRV) for knockin
of an EcoRV restriction site in EMX1 was co-transfected. Three days after transfection, genomic DNA was isolated from non-sorted cells or from cells
FACS isolated for low, medium or high fluorescence intensities and analysed by RFLP or CEL-I assay, as indicated. In all experiments, repeated three
times with similar results, PCR products containing amplicons derived from mutant alleles or from wild-type alleles only are indicated by the arrows and
asterisks, respectively. N.D.: none detected.
KRAS. After three days, the cells were left unsorted or
were FACS isolated for low, medium or high GFP expres-
sion levels and subsequently assayed for NHEJ modifica-
tion of the KRAS locus (triploid in K562 cells; Supplemen-
tary Table S6). In unsorted cells, ∼15% of the alleles were
modified, which increased to ∼24%, ∼41% and ∼59% in
cells displaying low, medium and high fluorescence levels,
respectively (Figure 5B). Qualitatively similar results were
obtained with the same construct in which the gRNA tar-
geted the VEGFA locus (Figure 5C, upper panel), which is
tetraploid in K562 cells (Supplementary Table S6). Thus,
2A-linked co-expression of fluorescent protein and Cas9
combinedwithFACScanalsobeusedtoeffectivelyincrease
genome editing frequencies in the CRISPR/Cas9 system.PAGE 13 OF 16 Nucleic Acids Research, 2014, Vol. 42, No. 10 e84
However with certain gRNAs, the CRISPR/Cas9 system
has recently been found to exhibit significant off-target cut-
ting (35–38).These include the particular VEGFA gRNA
used here, which was found to target additional genomic
sites with relatively high efficiency (36). We analysed two of
these sites and found that their modification also increased
upon FACS for high Cas9 expression levels, one of them to
the same extent as the on-target site (Figure 5C, middle and
lower panels).
To increase the utility of our method for CRISPR/Cas9-
based editing, we tested whether it functions in conjunc-
tion with CRISPR/Cas9 nickase mutant pairs, which ex-
hibit enhanced specificity, partly due to low indel mutagen-
esis rates by the individual nickases of the pair as compared
to CRISPR with wild-type Cas9 (12–14). Accordingly, we
demonstrated that the on- as well as off-target NHEJ muta-
genesisbytheVEGFACRISPR/Cas9constructobservedin
thetop-expressingcellsbyCEL-Iassayswasnon-detectable
with the D10A mutant nickase version of Cas9 (Cas9N (9))
(Figure 5C, last lane in all panels). Thus, the use of Cas9N
can reduce the level of off-target modification associated
with FACS for high-level Cas9 expression.
To incorporate Cas9N into our method, we generated
CRISPR/Cas9N pairs, in which one construct contained
Cas9Nthatwas2A-coupledtoGFPandtheotherconstruct
contained Cas9N 2A-coupled to DsRed2. K562 cells were
co-transfected with such a pair harbouring gRNA pairs
previously used to target the EMX1 locus (12). To further
assess our method for knockin editing, we co-transfected
an ssODN donor designed to introduce an EcoRV site in
the locus. Three days post-transfection, the cells were left
unsorted or were FACS isolated for low, medium or high
GFP/DsRed2 double-fluorescence levels. As we observed
for ZFN pairs, genome modification levels increased with
increasing fluorescence levels present in cells transfected
withCRISPR/Cas9N pairs(Figure 5D).Inthemost highly
fluorescent cell population, ∼11% of alleles of the EMX1
locus (triploid in K562 cells; Supplementary Table S6) were
knockin modified, as evidenced by RFLP assay. Total mod-
ification rates were ∼23%, as evidenced by CEL-I assay, in-
dicating NHEJ mutations in addition to the knockin modi-
fication. By contrast, no mutagenesis was detectable in top-
expressing cells after transfection with only one member of
theCRISPR/Cas9Npair(Figure5D).Qualitativelysimilar
resultswereobtainedwithanotherCRISPR/Cas9Npair,in
which one of the gRNAs was swapped for another EMX1
target sequence (Supplementary Figure S10).
DISCUSSION
We have developed a method for genome editing via 2A-
coupled co-expression of nuclease and fluorescent protein
followed by FACS enrichment of cells with high nucle-
ase levels. In the several and diverse variations tested, the
method was found to greatly increase genome editing effi-
ciencies of ZFNs as well as CRISPR/Cas9. In most cases,
thisoccurredinadose-dependentmanner:thehighernucle-
ase levels sorted for, the higher genome editing frequencies
achieved,bothforNHEJmutagenesisandforknockinedit-
ing.
Our data agree with the finding in the model system
of Certo et al. (21) that increased levels of nuclease re-
sult in increased levels of mutagenesis. In the present study,
we mainly delivered donors as ssODNs and nucleases as
mRNA. Whilst high knockin levels may also be achieved
withplasmid constructsfordonorsand nucleases,itisnote-
worthy that the herein used delivery forms work effectively
in our method, since ssODNs and mRNA have several ad-
vantages: first, ssODN donors can be obtained fast and in-
expensively. Second, nuclease expression from mRNA is in-
dependentofissuesrelatingtotheefficiency,orlackthereof,
of a given plasmid promoter in the targeted cell type. Third,
whenusingssODNandmRNAdelivery,editingcanbeper-
formed entirely without double-stranded DNA, thus min-
imizing the risk of random genomic integration of donor
and nuclease constructs, which by the nature of our method
are introduced in very high numbers when sorting for the
most efficiently transfected cells. Finally, we consider it
likely that the use of ssODN donors contributes to the high
knockin frequencies obtained in several of the present ex-
periments. Accordingly, we previously found that ssODNs
are more efficient than plasmids as donor in side-by-side
comparisons (15). The reason may be that the small size
of ssODN donors (∼100 bp) compared to plasmid donors
(4–6 kb) permits inclusion of a greater numerical level of
donor constructs in the transfection reaction, which should
ultimately increase knockin frequencies. This notion would
agree with the study by Certo et al. (21), showing that high
levels of donor promotes knockin editing at the expense of
NHEJ. Recently, fluorescent proteins have also been 2A-
coupled to TALENs followed by FACS for transfected cells
(39). Whilst this study did not enrich for specific nuclease
levels, it demonstrates that the fluorescent protein-2A strat-
egy also works for TALENs, which may therefore similarly
be used in the various enrichment protocols described here.
One advantage of 2A-coupled co-expression of nuclease
and fluorescent protein is that FACS enrichment for flu-
orescent cells guarantees that these cells also took up the
nuclease construct. For nucleases acting as a pair, the cou-
pling of each monomer to a distinct fluorescent protein fur-
thermoreensuresthatdouble-fluorescentcellstookupboth
monomers of the pair. The benefit of the dual labelling was
particularly evident in the Jurkat cells, where a substantial
fraction of cells appeared to express only one monomer of
the ZFN pair. Whilst both monomers need be present in
the cell, a 1:1 expression ratio may not be optimal for all
ZFN pairs (40). For such ZFN pairs, different amounts
of individual monomer constructs may be transfected, fol-
lowed by sorting for a population in which the individual
monomers are present both at optimal relative levels and
at as high levels as possible. The approach of 2A-coupling
both ZFNs of a pair to the same fluorescent protein, as in
pFP-ZFNL-ZFNR constructs, is another means to ensure
that FACS will only enrich for cells that have taken up both
ZFNs of a pair. This single vector strategy might be par-
ticularly useful for multiplex editing, in which ZFN pairs
for several different genes could each be linked to a distinct
colour for simultaneous multi-colour FACS enrichment of
cells in which several genes may have been modified. Fi-
nally,2A-coupledconstructshavetheadvantagethata‘nor-
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that the co-encoded nuclease construct is of good quality,
i.e. not degraded, a control that may be particularly use-
ful with labile RNA nuclease constructs. By contrast, non-
coupled co-expression of the fluorescence marker via a sep-
arate construct cannot guarantee that fluorescent cells have
also taken up the co-transfected nuclease. Such potential
discrepancy between fluorescence signal and nuclease up-
take may be part of the reason why we observed higher
genome editing frequencies with 2A-coupled co-expression
of the fluorescent protein and ZFN than with non-coupled
co-expression.
In the surrogate gene reporter strategy, nucleases are
co-transfected with a reporter that constitutively expresses
RFP to mark transfected cells and conditionally expresses
GFPuponindelmutagenesisofanucleasetargetsiteplaced
upstream of the GFP (20), thereby marking cells express-
ing active nuclease. The authors showed that FACS can
thereafterbeusedtosuccessfullyisolatecellpopulationsen-
riched for active nuclease and NHEJ-based mutation of the
chromosomal target gene. Compared to the surrogate re-
porter strategy, the present method allows for more donor
in the transfection reaction, can be performed without the
use of double-stranded DNA, has more fluorescence mark-
ers available for multi-plexing (since none are used for a re-
porterconstruct)anddoesnotrequireconstructionofasur-
rogate reporter target site. Furthermore, since fluorescence
signal in the 2A-coupled approach is a more direct measure
of nuclease levels, it may be easier to balance nuclease levels
foranoptimalon/off-targetratiousingthepresentmethod,
as discussed below.
Although ZFNs are rather specific reagents, off-target
cleavage can occur and may increase at elevated levels of
nuclease (33,41). However, for the most exhaustively char-
acterized ZFNs in this study (RSK4 and RSK2), we found
no mutations in top candidate off-target sites in cells en-
riched for very high ZFN levels, using a depth of analysis
that should detect off-target rates occurring with >1% on
average.Furthermore,analysisofanumberofCHOknock-
out clones generated using our method also suggested very
modest off-target effects. It should be noted, however, that
the extent of off-target cutting is inherently dependent on
ZFN design. The ZFNs used here had no predictable off-
target sites with less than four nucleotide mismatches com-
pared to the on-target site. Furthermore, the target sites
were 30–33 bps long in total. It is possible that higher off-
target levels will be observed in top-expressing cells if ZFNs
with off-target sites containing fewer mismatches and/or
having shorter target sites are used. Both of these features
promote off-target cutting and were features of several of
the ZFNs used in the aforementioned studies on the off-
target activity of ZFNs. It should also be noted that we
only analysed predictable off-target sites (i.e. homologous
off-target sites), and thus did not address potential off-
target actions at non-homologous sites, which would re-
quirewhole-genomesequencingorotherunbiasedgenome-
widestrategies(33).Nevertheless,atthispointourdatasug-
gest that with ZFN designs similar to those used here, off-
target effects associated with our method are very modest
and that it seems easy to derive clones with no modifica-
tions in predictable off-target sites.
Interestingly,intheonecaseinwhichoff-targetmutagen-
esis occurred at high ZFN levels, it was possible to choose a
cell population with medium ZFN levels, which eliminated
detectable off-target cutting, whilst maintaining high rates
of on-target modification. We speculate that mismatches in
off-target sites render their cutting more sensitive to de-
creasing ZFN concentrations than the on-target-site, a no-
tionsupportedbyZFNoff-targetanalysesinvitro(41),such
that nuclease levels can be obtained where on-target cut-
ting is relatively much higher than the off-target event, as
compared to saturating doses of nuclease. With the current
knowledge on ZFN action it is not possible to predict ap r i -
orianoptimalZFNexpressionlevelshowingthedesiredon-
and off-target cutting ratio. This must be determined on a
case-by-case basis, for example, by performing experiments
like the one shown in Supplementary Figure S9B. Such ex-
periments may be able to identify a cell population with a
suitable nuclease level, which may subsequently be used to
generate modified cell clones or cell pools.
Regarding the CRISPR/Cas9 system, the VEGFA con-
struct used here produced increased cutting at certain off-
target sites upon FACS for high nuclease levels. These find-
ings agree with previous studies that some gRNAs, in-
cluding the present VEGFA gRNA, exhibit significant off-
target actions that may increase with increasing amounts
of gRNA (35–38). Although we did not test the possibil-
ity, in some cases our method might be used to balance
CRISPR/Cas9 on- and off-target effects in the same man-
ner we showed for ZFNs. However, this will not be possi-
ble for certain gRNAs, as exemplified in the present case
with VEGFA, in which the on-target site and off-target site
1 were mutated to the same extent at the various expres-
sion levels. It is possible that more careful design and/or
new developments in the design of gRNA, such as de-
s c r i b e di n( 13), may ameliorate the off-target issue of our
method applied with CRISPR/Cas. However, it is notewor-
thy that our method also increased the genome editing ef-
ficiency of CRISPR/Cas9N nickase pairs, a version of the
CRISPR/Cas9 system that shows greatly improved speci-
ficity (12–14). The individual CRISPR/Cas9Ns of a pair
will likely show increased off-target nicking upon FACS
enrichment for high Cas9N levels. However, since DNA
single-strand breaks are predominantly repaired by the
high-fidelity base excision repair pathway (42), off-target
nicks will rarely be mutagenic. Accordingly, we detected
no indel mutagenic effects of individual CRISPR/Cas9Ns
in cells sorted for high-level expression of such constructs.
Another reason for the higher specificity of CRISPR/Cas9
nickase pairs is a combined target sequence that is twice as
long as that of an individual CRISPR/Cas9 construct. Al-
together, nickase pairs seem a particularly safe version of
the CRISPR/Cas9 genome editing system for use in our
method.
We primarily validated our method by assessing genome
editing in stably modified clonal cell lines or stable cell
pools. This is opposed to assessing editing in genomic
DNA from cell pools 3 days after transfection with edit-
ing reagents, as is often performed, but which may not
be a reliable indicator of stable modification rates. For in-
stance, in our hands and in the hands of others, modifica-
tion rates observed 3 days post transfection can be many-PAGE 15 OF 16 Nucleic Acids Research, 2014, Vol. 42, No. 10 e84
fold higher than those eventually observed in stably mod-
ified cells (15,20). Altogether, we validated our method in
a very large set of clonal cell lines (>4000), of which 426
weremonoallelicand648werebiallelicknockinclones.This
also highlights that in some cases our method can serve
as a high-throughput strategy for generation of targeted
knockin clones. The ability to generate many clones with
the same mutation may be a powerful means to minimize
the confounding impact of clonal variation on downstream
functional analyses, a problem inherent to most studies on
clonalcelllines.Forexample,25knockinclonesmaybegen-
erated,pooledandsubjectedtophenotypicanalysis,astrat-
egy that may effectively dilute out non-nuclease-derived
phenotypicdifferencesofindividualclonesintheoverallre-
sults achieved when studying the clone pool. A similar ben-
efit may be obtained by studying cell pools with close-to-
complete genome modification via consecutive rounds of
ZFN transfections and FACS on a cell population, as we
also found feasible in the present study.
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